Unlike traditional oral solid dosage products, oral GLP-1s require a distinct set of capabilities spanning advanced formulation and delivery science, specialised oral manufacturing for biologics, robust scale-up and lifecycle management, and resilient, high-quality supply chains
Targeted enforcement, with the aid of monitoring technology, to find problem ads for removal and sanction came into effect on 12 June 2020
In heart and kidney transplant recipients, common FDA-approved SGLT-2 drugs such as empagliflozin and canagliflozin improve weight, blood pressure, and glycemic control
Through a lot-specific Certificate of Analysis showing: mass-spectrometry identity (expected ~1419.5 Da), HPLC purity (typically 98%), net peptide content, and a matched lot number
Medications: Prescribing weight loss medications when appropriate